Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Evaluating the value of travel points against cash back can impact your rewards strategy. Discover which option offers the greatest benefits for your needs.
26,201 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Paramount Global and Skydance are stepping up with a bigger offer for Warner Bros. Discovery, aiming to outpace Netfl...
A surge of XRP tokens flowed into Binance amid weekend geopolitical shocks, signaling potential near-term price press...
Analysts debate whether $150 won’t hurt broadcom’s near-term earnings, as Broadcom’s AI backlog powers growth. The bu...
A fresh examination of the innovations powering U.S. military dominance and how investors are pricing defense names i...
Choosing the right global real estate ETF can boost income and diversification. This guide compares VNQI and REET, hi...
When you’re choosing tech stock exposure, the decision often comes down to cost, diversification, and tilt. This deep...
Tim Cook’s stock sale near Apple’s highs is sparking fresh debate about capital allocation in tech. An analyst argues...
A Qatar LNG outage and resilient U.S. shale growth have kept Henry Hub prices subdued, creating a rare price setup th...
A national review identifies about 82,000 2023 FHA mortgages with small subordinate liens, totaling roughly $880 mill...
SpaceX is shaping up to launch its IPO, and the idea of could buying spacex stock sounds thrilling. This guide breaks...
A California crypto executive dubbed 'The Godfather' pleads guilty to conspiring in a scheme tied to a $245 million b...